You have 9 free searches left this month | for more free features.

Tertiary lymphoid structures

Showing 1 - 25 of 3,182

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumor Trial in Bordeaux (MEDI5752)

Not yet recruiting
  • Advanced Solid Tumor
  • Bordeaux, France
    Institut Bergonie
May 24, 2023

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

Cancer Trial in Villejuif (Pembrolizumab, Pembrolizumab and Olaparib, Pembrolizumab adjuvant)

Not yet recruiting
  • Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Oct 30, 2023

Autoimmune Bullous Disease Trial in Seoul (Biopsy)

Recruiting
  • Autoimmune Bullous Disease
  • Biopsy
  • Seoul, Korea, Republic of
    GangnamSeverance Hospital
Mar 14, 2022

Chronic Rhinosinusitis With Nasal Polyps Trial in Vancouver (Mepolizumab)

Not yet recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Vancouver, British Columbia, Canada
    St. Paul's Sinus Centre
Oct 24, 2023

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Atezolizumab
  • +5 more
  • (no location specified)
Feb 4, 2023

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Bintrafusp alfa, Doxorubicin)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +7 more
Dec 6, 2021

Locally Advanced Undifferentiated Pleomorphic Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Recurrent

Recruiting
  • Locally Advanced Undifferentiated Pleomorphic Sarcoma
  • +3 more
  • Sintilimab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

COLON-IM : Microbiota and Immune Infiltrate in Normal,

Recruiting
  • Colorectal Cancer
    • Lyon, France
    • +1 more
    Jul 22, 2022

    MUltiple Sclerosis : T Cell / B Cell Exploration

    Completed
    • Multiple Sclerosis
      • Rennes, France
        Rennes University Hospital
      Dec 1, 2021

      Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)

      Recruiting
      • Malignant Pleural Mesothelioma
      • Safety
      • Expansion Cohort
      • New York, New York
        Icahn School of Medicine Mount Sinai
      Mar 31, 2022

      Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

      Recruiting
      • Multiple Sclerosis, Secondary Progressive
      • Multiple Sclerosis
      • Cladribine Subcutaneous Injection
      • 0.9% Chloride Injection Sodium
      • Warsaw, Mazowieckie, Poland
        Institute of Psychiatry and Neurology
      Jul 26, 2023

      Diagnosis, Axilla; Breast Trial in Ankara (Ultrasound and biyopsy)

      Completed
      • Diagnosis
      • Axilla; Breast
      • Ultrasound and biyopsy
      • Ankara, Turkey
        Ankara Education and Research Hospital
      Jun 25, 2023

      Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris

      Recruiting
      • Pemphigus Vulgaris
      • +2 more
        • Mexico City, Mexico
        • +1 more
        Aug 8, 2022

        Q Angle in Static and Dynamic Postures

        Recruiting
        • Quadriceps Muscle
        • Orthopedic Disorder
        • Evaluation of q angles different positions
        • +2 more
        • Istanbul, Turkey
          Istanbul University-Cerrahpaşa
        May 31, 2023

        Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

        Recruiting
        • Mantle Cell Lymphoma
        • +9 more
        • L-Bcl-2 antisense oligonucleotide
        • Augusta, Georgia
        • +2 more
        Nov 18, 2022

        Helicobacter Pylori Infection in Patients With Chronic Tonsillits Trial in Sohag (Rapid urease test for h pylori)

        Recruiting
        • Helicobacter Pylori Infection in Patients With Chronic Tonsillits
        • Rapid urease test for h pylori
        • Sohag, Egypt
          Sohag university Hospital
        Oct 31, 2023

        Sacral Neuromodulation Trial (sacral neuromodulation)

        Completed
        • Sacral Neuromodulation
        • sacral neuromodulation
        • (no location specified)
        Oct 22, 2023

        A Greek-designed ERAS Protocol in Elective Craniotomy

        Recruiting
        • ERAS
        • Craniotomy
        • ERAS
        • Larissa, Greece
          University of Thessaly
        Jul 26, 2023

        Lymphoma, B-Cell, Leukemia, B-cell, Leukemia, T-Cell Trial in Cangzhou (CAR-T)

        Recruiting
        • Lymphoma, B-Cell
        • +3 more
        • CAR-T
        • Cangzhou, Hebei, China
          Cangzhou People's Hospital
        Nov 9, 2022

        The Lymphoid Tissue Pharmacology of Antiretroviral Drugs

        Not yet recruiting
        • HIV Infection
        • Anti-HIV Agents
        • (no location specified)
        Nov 4, 2022

        T-cell Lymphoma, CLL/SLL Trial in Birmingham (Tazemetostat, Acalabrutinib and Tazemetostat)

        Not yet recruiting
        • T-cell Lymphoma
        • CLL/SLL
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Aug 11, 2023

        Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)

        Recruiting
        • Acute Myeloid Leukemia
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • +7 more
        • Duarte, California
          City of Hope Medical Center
        Jun 8, 2022

        Relapsed Lymphoid Malignancies, Refractory Lymphoid Malignancies Trial in Bentleigh (CN1, 0.5mg/kg and CN401, 400mg, CN1, 1mg/kg

        Terminated
        • Relapsed Lymphoid Malignancies
        • Refractory Lymphoid Malignancies
        • CN1, 0.5mg/kg and CN401, 400mg
        • +4 more
        • Bentleigh, Victoria, Australia
          Monash Health - Monash Medical Centre
        Oct 20, 2022